First report of invasive Aspergillus rhinosinusitis in a critically ill COVID‐19 patient affected by acute myeloid leukemia, northeastern Iran
Author(s) -
Hosseinikargar Neginsadat,
Basiri Reza,
Asadzadeh Mohammad,
Najafzadeh Mohammad Javad,
Zarrinfar Hossein
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4889
Subject(s) - medicine , critically ill , mucormycosis , myeloid leukemia , covid-19 , aspergillus , leukemia , aspergillosis , intensive care medicine , sinusitis , dermatology , immunology , pathology , disease , microbiology and biotechnology , infectious disease (medical specialty) , biology
This is a report of established invasive Aspergillus rhinosinusitis in a patient diagnosed with COVID‐19 and afflicted by AML, which was initially considered to be rhinocerebral mucormycosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom